Pediatric Cancer Helped By Genetically Engineered T Cells

Two infants diagnosed with a relapsed form of childhood cancer who had previously exhausted all other treatment options remain disease-free after receiving a first-in-human experimental therapy that uses genetically engineered T cells, a new analysis reports. Such cell-based approaches have been difficult to implement in young children, a population in which B cell acute lymphoblastic leukemia (ALL) is highly prevalent, representing 25% of all pediatric cancer cases in the United States. Several options exist for treating ALL in children between … Read More

Non-Adherence To Taking Cancer Drugs Affects Oral Cancer Treatment Outcomes

The development of oral cancer drugs as a modality therapy over the last decade has highlighted the problem of non-adherence. Only cancer drugs that are taken can actually work. Contrary to what is expected, a significant share of cancer patients doesn’t take their cancer drugs as prescribed. Presented at the ESMO Congress 2016, the results of a new study by Professor Florence Joly and Dr Melanie Dos Santos of the Centre Francois Baclesse in Caen, on the “Impact of cognitive … Read More

Early-stage Esophageal Cancer Survival Rates Improves With Treatment

Esophageal cancer is the eighth most common cancer worldwide and the sixth most common cause of death related to cancer. In the United States, there are over 16,000 people diagnosed with the disease annually with an even higher prevalence in other parts of the world. The National Comprehensive Cancer Network (NCCN) guidelines suggest surgery as the standard treatment for stage I esophageal cancer. Despite these guidelines, various factors prevent a patient from being managed surgically such as age of the … Read More

How are EGFR (Epidermal Growth Factor Receptors) Connected To Cancer?

EGFR (Epidermal Growth Factor Receptors) are involved in the development and progression of many types of cancer and bowel cancer (colon carcinoma) in particular. So-called anti-EGFR antibodies are used in the treatment of bowel cancer patients, to inhibit EGFR. However, for reasons that are not yet clear, not all patients benefit from this treatment. This could be due to the fact that EGFR is not only found in the tumor cells of bowel cancer patients but also in the immune … Read More

The Difference Between Standard (X-Ray) Radiation Treatment And Proton Therapy

There is a significant difference between standard (x-ray) radiation treatment and proton therapy. If given in sufficient doses, x-ray radiation techniques will control many cancers. But, because of the physician’s inability to adequately conform the irradiation pattern to the cancer, healthy tissues may receive a similar dose and can be damaged. Consequently, a less- than-desired dose is frequently used to reduce damage to healthy tissues and avoid unwanted side effects. The power of protons is that higher doses of radiation … Read More

There are 2 types of cancer vaccines: Prevention vaccines and Treatment vaccines

Vaccines, also called vaccinations, are medicines that help the body fight disease. They help train the immune system to recognize and destroy harmful substances. There are 2 types of cancer vaccines: Prevention vaccines Treatment vaccines Cancer prevention vaccines Doctors give prevention vaccines to healthy people to keep certain cancers from developing. Like vaccines for the chicken pox or the flu, they protect the body from viruses that can cause disease. A person has to get the vaccine before the virus … Read More